5AM Venture Management’s Centessa Pharmaceuticals CNTA Stock Holding History

5AM Venture Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.1M	Hold	580,945	–	–	6.41%	5
2025 Q4	$14.5M	Sell	580,945 -100,000	-15%	-$2.53M	4.57%	9
2025 Q3	$16.5M	Sell	680,945 -150,000	-18%	-$2.67M	6.05%	5
2025 Q2	$10.9M	Hold	830,945	–	–	4.2%	7
2025 Q1	$11.9M	Hold	830,945	–	–	4.52%	6
2024 Q4	$13.9M	Sell	830,945 -454,055	-35%	-$7.52M	3.32%	12
2024 Q3	$20.5M	Buy	1,285,000 +40,000	+3%	+$490K	4.25%	8
2024 Q2	$11.2M	Hold	1,245,000	–	–	2.51%	13
2024 Q1	$14.1M	Buy	+1,245,000	New	+$11.8M	3.15%	14

Other funds holding CNTA

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

IVLAV

Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

5AM Venture Management's CNTA Position: Q1 2026 in Review

5AM Venture Management held its Centessa Pharmaceuticals (CNTA) position steady in Q1 2026 at 580,945 shares worth $23.1M. The position accounts for 6.41% of the portfolio, ranked #5.

5AM Venture Management first reported a position in CNTA in Q1 2024 and has held it in 9 quarters since. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

5AM Venture Management held 580,945 shares of Centessa Pharmaceuticals worth $23.1M as of Q1 2026.
5AM Venture Management left its Centessa Pharmaceuticals share count unchanged in Q1 2026.
Centessa Pharmaceuticals made up 6.41% of 5AM Venture Management's portfolio in Q1 2026, its #5 holding.
5AM Venture Management first reported a position in Centessa Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on 5AM Venture Management's 13F filing for Q1 2026, filed 15 May 2026.